期刊
MOLECULAR CANCER
卷 12, 期 -, 页码 -出版社
BMC
DOI: 10.1186/1476-4598-12-165
关键词
Breast cancer; Phospholipase C-beta 2 (PLC-beta 2); CD133; Tumor progression
资金
- Italian MIUR [PRIN 200938XJLA_003, FIRB RBAP10Z7FS_002]
- University of Ferrara (Italy)
Background: Beyond its possible correlation with stemness of tumor cells, CD133/prominin1 is considered an important marker in breast cancer, since it correlates with tumor size, metastasis and clinical stage of triple-negative breast cancers (TNBC), to date the highest risk breast neoplasia. Methods: To study the correlation between the levels of CD133 expression and the biology of breast-derived cells, CD133(low) and CD133(high) cell subpopulations isolated from triple negative MDA MB 231 cells were compared in terms of malignant properties and protein expression. Results: High expression of CD133 characterizes cells with larger adhesion area, lower proliferation rate and reduced migration speed, indicative of a less undifferentiated phenotype. Conversely, when compared with CD133(low) cells, CD133(high) cells show higher invasive capability and increased expression of proteins involved in metastasis and drug-resistance of breast tumors. Among the signalling proteins examined, PLC-beta 2 expression inversely correlates with the levels of CD133 and has a role in inducing the CD133(high) cells to CD133(low) cells conversion, suggesting that, in TNBC cells, the de-regulation of this PLC isoform is responsible of the switch from an early to a mature tumoral phenotype also by reducing the expression of CD133. Conclusions: Since CD133 plays a role in determining the invasiveness of CD133(high) cells, it may constitute an attractive target to reduce the metastatic potential of TNBC. In addition, our data showing that the forced up-regulation of PLC-beta 2 counteracts the invasiveness of CD133-positive MDA-MB-231 cells might contribute to identify unexplored key steps responsible for the TNBC high malignancy, to be considered for potential therapeutic strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据